Gastrointestinal Cancer News

Nearly seven in 10 premature cancer-related deaths among women could have been avoided through primary prevention, early detection or suitable access to cancer care, according to a report.

New diagnoses for six of the most common cancer types sharply declined in the U.S. in early 2020 — along with the volume of pathology reports — largely due to the start of the COVID-19 pandemic, according to data released by NCI.

The addition of a radioligand therapy to first-line treatment with long-acting octreotide prolonged PFS for patients with gastroenteropancreatic neuroendocrine tumors, according to the agent’s manufacturer.

Being breastfed in infancy was associated with a 23% increased risk for colorectal cancer in adulthood, especially among women younger than 50 years, according to a study in Clinical Gastroenterology and Hepatology.

Patients with Barrett’s esophagus who underwent anti-reflux surgery had an increased risk for esophageal adenocarcinoma over time compared with patients who used anti-reflux medication, according to research.

Although previous data has demonstrated a possible link between tea consumption and a reduced risk for colorectal cancer, researchers reported the actual effect on risk ranges from a reduction of 51% to an increase of 18%.

Results from the American Association for Cancer Research’s annual Cancer Progress Report revealed that the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2020.

Primary care providers play a key role in cancer survivorship, according to a presenter at the Cancer Center Survivorship Research Forum.

The FDA announced several regulatory actions the past few weeks.

Fecal immunochemical test-based screening was effective in detecting early-stage colorectal cancer at first and repeat screenings, with higher FIT cutoff levels having little effect on stage distribution, data showed.